CVS Health Corp (NYSE:CVS) currently has a daily average trading volume of 13.69M but it saw 14968492 shares traded in last market. With a market cap of 68.26B USD, the company’s current market price of $54.24 came falling about -2.60 while comparing to the previous closing price of $55.69. In past 52 weeks, the stock remained buoying in the range of price level as high as $80.75 and as low as $43.56. In the recent trading on the day, stock has struck highest price mark of $53.84 while lowest mark touched by it was $55.98.
Taking a look at 20-day trading activity of CVS Health Corp (CVS) gives us an average price of $53.72, while its current price level is -32.83% below from 52-week high level whereas it is 24.52% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $51.88 while that of 200 days or SMA-200 reads an average of $57.21. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.76% during that period while stretching the period over a month that increases to 2.93%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 54.81 which implies that the stock is in neutral territory.
Deutsche Bank upgraded its recommendation for the stock as a “Buy” from “Hold” on December 03, 2024 while assigning a price target of $66. Wells Fargo also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $60 and $66.
Over the week, CVS’s stock price is moving -4.54% down while it is 18.38% when we observe its performance for the past one month. Year-to-date it is 20.83% up and over the past year, the stock is showing a downside performance of -25.12%.
Currently, CVS Health Corp’s total number of outstanding shares is 1.26B with 0.13% of that held by the insiders while 81.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 3.34% and return on equity (ROE) at 6.72%. It has a price to earnings ratio (P/E ratio) of 13.78 while having a 9.24 of forward P/E ratio. Stock’s beta reads 0.56. Stock has a price to book (P/B) ratio of 0.91 while price to sale or P/S ratio amounts to 0.18. Its return on asset (ROA) is 1.99% on average.
